We’re called Q’Apel for the Qu’Appelle River, a waterway that winds through Saskatchewan, Canada. Why? Because this pristine river charts a winding path, full of twists, turns, and straightaways alike. That’s what we do, too. Our cutting-edge products—neurological catheters, specifically—are designed to navigate the twists and turns of the brain’s neurovasculature, empowering therapeutic thrombectomy and cerebral aneurysm devices to deliver life-changing outcomes.
Q'Apel Medical announced today that industry veteran King Nelson is joining the company as CEO.
Nelson brings more than three decades of experience as a medical device executive and has extensive background in new product development, marketing and commercialization. Prior to Q’Apel, Nelson served as President and CEO of Uptake Medical, Kerberos Solutions and VenPro Cardiovascular.
I am delighted to join the terrific team at Q’Apel Medical and look forward to continuing the great legacy of success built by Jim Dreher. I am excited to help guide the organization through the crucial next steps of scaling manufacturing and our upcoming commercial product release of the walrus BGC in the U.S.
King Nelson, Q’Apel Medical CEO
The walrus BGC represents the second FDA-cleared technology from Q’Apel in the past 12 months, joining the wahoo Access Catheter with Selectflex technology in Q’Apel’s expanding product portfolio. Q’Apel has several more innovative products slated to come to market in the near future.
“The team at Q’Apel is developing the most innovative products used in neurovascular interventions. We are excited about the future of Q’Apel and believe King brings the experience and leadership needed to take Q’Apel to the next level of success,” said Chris Martin, Director, Q’Apel Medical.